5-<(methylcarboxy)methyl>uridine, also known as 1,2,3,4-tetrahydro-2,4-dioxo-1-β-D-ribofuranosyl-5-pyrimidineacetic acid methyl ester, is a chemically modified nucleoside derivative. Its structure is based on uridine, a natural ribonucleoside, with a methyl carboxymethyl group substituted at the 5-position of the uracil base. This modification introduces a reactive carboxylic ester functional group onto the nucleobase scaffold. This compound serves as a key intermediate in the synthesis of more complex nucleoside analogs and modified oligonucleotides. Its primary application is in medicinal chemistry and life science research, particularly for the development of antiviral and anticancer agents. The reactive ester group allows for further chemical elaboration, making it a valuable building block for creating nucleoside prodrugs or for attaching fluorescent labels, bioconjugation handles, or other functional moieties to the nucleoside core for biological studies. As a modified pyrimidine ribonucleoside, it falls under the category of nucleoside chemistry tools. It is used in research exploring RNA biology, nucleic acid therapeutics, and as a precursor for novel bioactive molecules targeting various enzymes and pathways involved in nucleotide metabolism.